Irritation relieving agent, production method thereof and skin external preparation
A sulfated polysaccharide salt, derived from Funori and formed with monovalent cations, addresses the challenge of skin irritation from cosmetics and pharmaceuticals by effectively alleviating irritation in small concentrations.
Patent Information
- Application Number
- JP2023077229
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-09
- Publication Date
- 2024-11-21
AI Technical Summary
Existing cosmetic and pharmaceutical ingredients can cause skin irritation, particularly lactic acid, and there is a lack of a naturally-derived, safe, and stable irritation reliever that effectively alleviates this issue.
A sulfated polysaccharide salt, such as the sodium salt of Funori, is used as an irritation reliever, formed by a specific extraction method, which forms a salt with a monovalent cation and contains hexose constituent units with sulfate groups, particularly at the 4 and/or 6 positions, to alleviate skin irritation.
The sulfated polysaccharide salt effectively reduces skin irritation caused by cosmetics and pharmaceuticals even in extremely small amounts, providing a safe and stable solution.
Smart Images

Figure 2024162057000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to an irritation-relieving agent that is added to a composition that comes into contact with the skin, such as a cosmetic or pharmaceutical composition, a method for producing the same, and an external preparation for the skin. [Background technology]
[0002] Since safety is important for cosmetic ingredients, they are used in a concentration range that causes little skin irritation. However, when the barrier function of the skin is reduced, even ingredients that generally cause little skin irritation may cause skin irritation. In order to reduce skin irritation, ingredients that repair the skin barrier function and ingredients that reduce the irritation of other ingredients have been reported. For example, Patent Document 1 discloses that a composition containing carbohydrates or their derivatives as an active ingredient reduces skin irritation caused by dyes and prevents or prevents inflammation caused by dyes. Specific examples of carbohydrates or their derivatives include one or more selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides.
[0003] Patent Document 2 discloses that polysaccharides (levan) produced by the action of microbial enzymes have the effect of mitigating skin irritation. Levan is a fructose polymer with β(2→6) bonds, and is produced by various microorganisms such as Bacillus subtilis using sucrose as a substrate. However, there has not been a naturally derived irritation mitigating agent that sufficiently suppresses the irritation caused by lactic acid, a typical irritant in cosmetics, and that is safe and stable in itself. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Special Publication No. 2013-511512 [Patent Document 2] JP 2003-277225 A Summary of the Invention [Problem to be solved by the invention]
[0005] The present invention has been made in consideration of the above circumstances, and has an object to provide an irritation alleviator which is highly safe and has excellent irritation suppression ability. [Means for solving the problem]
[0006] As a result of intensive research to solve the above problems, the inventors have found that there is a polysaccharide molecule with a specific structure that exhibits excellent functionality in Funori polysaccharides extracted from Funori by a specific extraction method, and that by adding it to a skin topical agent, it is possible to alleviate irritation caused by medicines and cosmetics on the skin. That is, the present invention includes the following embodiments.
[0007] (1) An irritation-relieving agent comprising a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, the sulfate group forming a salt with a monovalent cation. (2) An irritation-relieving agent as described in (1), in which the sulfated polysaccharide salt has one or more hexose structural units selected from the group consisting of fucose, rhamnose, galactose, glucose, mannose and fructose, and at least one of the hexose structural units has a sulfate group. (3) An irritation-relieving agent according to (1), in which the sulfated polysaccharide salt is the sodium salt of funoran, a polysaccharide derived from Funori. (4) A skin topical preparation comprising the irritation-relieving agent according to any one of (1) to (3) in an amount of 0.000001% by mass to 0.01% by mass calculated as the solid content of the sulfated polysaccharide salt. (5) A method for producing an irritation alleviator, comprising the steps of dissolving funori powder in water to prepare a funori aqueous solution, adding a monovalent cation to the funori aqueous solution and heating it, and molecular weight fractionating the heated aqueous solution to recover a sulfated polysaccharide salt. (6) A method for producing an irritation alleviator, comprising the steps of: dissolving funori powder in water to prepare a funori aqueous solution; adding an acid to the funori aqueous solution to make it acidic, and then desalting it; neutralizing the desalted aqueous solution by adding a monovalent cation; and molecular weight fractionating the neutralized aqueous solution to recover sulfated polysaccharide salts. Effect of the Invention
[0008] The irritation-relieving agent according to the present invention can reduce skin irritation caused by medicines and cosmetics even when used in extremely small amounts. [Brief description of the drawings]
[0009] [Figure 1] FIG. 1 shows the results of the irritation alleviation test of Funoran Na conducted in Example 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Below, we will explain in detail the irritation-relieving agent and its manufacturing method according to embodiments of the present invention, as well as the topical skin preparation containing this irritation-relieving agent. However, not all of the elements and combinations of elements described in each embodiment are necessarily essential to the solution of the present invention.
[0011] (Irritant) The irritation alleviating agent according to the present embodiment is characterized by containing, as an active ingredient, a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, and in which the sulfate group forms a salt with a monovalent cation. The structure of the polysaccharide constituting this sulfated polysaccharide salt is not particularly limited, as long as it has a sulfate group in at least one sugar unit structure. The sugar unit structure preferably contains hexose, and may be a homopolysaccharide composed of one type of hexose unit, or a heteropolysaccharide containing at least one type of hexose unit and two or more types of sugar unit.
[0012] In the case of heteropolysaccharides, the sugar building blocks other than at least one hexose building block may be any of triose building blocks, tetraose building blocks, pentose building blocks or hexose building blocks, and any combination of these may be used to form two or more sugar building blocks.
[0013] The hexose unit contained in the polysaccharide constituting the sulfated polysaccharide salt according to the present embodiment is not particularly limited and may be, for example, any of fucose, rhamnose, galactose, glucose, mannose and fructose, and includes those having one or more hexose units among these, and at least a sulfate group may be present in the hexose unit.
[0014] The sulfated polysaccharide salt according to the present embodiment may have a sulfate group at any position in the saccharide unit structure of the polysaccharide constituting the salt, for example, at the 2-, 3-, 4-, 5-, and / or 6-positions of the hexose structural unit, preferably at the 4- and / or 6-positions, and most preferably at the 6-position. For example, the OH at the 4-position of fucose and the OH at the 6-position of galactose may be sulfated (semi-sulfate ester).
[0015] In addition, in the saccharide unit structure of the polysaccharide constituting the sulfated polysaccharide salt according to the present embodiment, as long as at least a part of the hexose structural unit has a sulfate group, it is not particularly limited, but it is desirable that the structural unit having a sulfate group is contained in a proportion of, for example, 0.1 to 100%, preferably 1 to 100%, 10 to 100%, 30 to 100%, 40 to 100%, 50 to 100% of the total saccharide unit structures constituting the sulfated polysaccharide salt. Furthermore, if 50% or more, preferably 60% or more, 70% or more, 80% or more, 90% or more, 95% or more of the total saccharide unit structures have hexose structural units having sulfate groups, the effect is substantially the same as that of 100% of the total saccharide unit structures having saccharide unit structures having sulfate groups.
[0016] The sulfated polysaccharide salt according to this embodiment further contains a monovalent cation, for example, Na + , K + , NH4 + etc., preferably Na + and K + , particularly preferably Na + In other words, the polysaccharides having sulfate groups as described above cannot exhibit their intended functions unless they are in the form of a salt, due to autohydrolysis. 2+ It has been revealed that, even if the sulfated polysaccharide salt has a sulfate group in the sugar unit structure, when the divalent cation is such as calcium, it does not exhibit an irritation alleviating function such as alleviating irritation caused by medicines or cosmetics on the skin, and only when the salt is a monovalent cation, such an irritation alleviating function is exhibited. Therefore, it is preferable that the sulfated polysaccharide salt according to the present invention is substantially free of divalent cations such as calcium. Here, "substantially free" means, for example, that the amount present is 5% or less, 1% or less, 0.1% or less, 0.01% or less, or 0.001% or less in molar units, and more preferably, an amount close to zero or less.
[0017] The sulfated polysaccharide salt according to the present embodiment may be either one obtained by synthesis or one extracted from various natural raw materials, so long as it has the structure described above, but is preferably one of natural origin, and in particular one derived from Funori, such as sodium salt of Funoran, is desirable. Funori is a seaweed belonging to the red algae, Funoriaceae family, Funori genus (scientific name: Gloiopeltis), and in Japan, Fukuro Funori, Mafunori, and Hana Funori are well known. The Funori used in the present invention may be one obtained by removing foreign matter from these seaweeds, appropriately refining, drying, shearing or powdering, or one obtained by first obtaining an extract and then granulating or powdering it.
[0018] Although not particularly limited, examples of sulfated polysaccharide salts related to the sodium salt of funoran include those having the structural formula shown below. [ka] (However, in these formulas, n is 1 to 20,000, and more preferably, for example, 1 to 10,000, 10 to 8,000, 100 to 5,000, 200 to 4,000, or 1,000 to 2,000.)
[0019] The irritation mitigating agent according to the present embodiment contains the above-mentioned sulfated polysaccharide salt, and the content thereof can be adjusted to a desired concentration of 0.00001% by mass to 99% by mass calculated as the solid content of the sulfated polysaccharide salt. The irritation mitigating agent according to the present embodiment is an ingredient that mitigates the irritation of other ingredients, and is preferably used as an additive for producing pharmaceuticals or cosmetics containing desired active ingredients.
[0020] (External skin preparations) The external skin preparation according to this embodiment contains the above-mentioned irritation-relieving agent. Examples of external skin preparations of the present embodiment include basic cosmetics such as lotion, milky lotion, cream, ointment, lotion, oil, and pack; skin cleansing agents such as soap, cleansing cream, cleansing lotion, and facial cleanser; hair washing cosmetics such as shampoo, rinse, and treatment; hair styling products such as hair cream, hair spray, hair tonic, hair gel, hair lotion, hair oil, hair essence, hair water, hair wax, and hair foam; hair growth and hair care products; foundations, face powders, and other products. Examples of such cosmetic products include makeup cosmetics such as face powder, lipstick, blusher, eye shadow, eyeliner, mascara, eyebrow pencil, and eyelashes; finishing cosmetics such as nail beautifiers; cosmetic compositions such as perfumes, toothpastes, and oral compositions such as mouthwash; medicated oral compositions such as topical medicinal preparations, ointments, poultices, bath products, medicated toothpastes, and mouth fresheners; medicated cosmetics, hair dyes, hair growth agents, hair loss prevention agents, hair removers and other hair solvents and deodorizers; sanitary products, sanitary cotton, wet tissues and other external quasi-drugs; and topical medicines.
[0021] The content of the irritation alleviating agent in the skin external preparation according to this embodiment is not particularly limited, but for example, in a composition in the form of an aqueous solution, even with a very small amount of sulfated polysaccharide salt, such as 0.000001% by mass or more, preferably 0.00001% by mass or more, more preferably 0.0001% by mass or more, based on the solid content of the sulfated polysaccharide salt relative to the entire skin external preparation, a very good skin irritation alleviating effect can be exhibited. The upper limit of the amount of the irritation alleviating agent is not particularly limited, but from an economical standpoint, it is preferably 0.1% by mass or less, particularly 0.05% by mass, and even more preferably 0.01% by mass or less. A particularly preferred range is 0.00005% by mass to 0.0005% by mass.
[0022] In addition to the above-mentioned components, the above-mentioned skin topical preparations can contain various cosmetic ingredients selected appropriately from the following substances depending on the required efficacy and effect, such as commonly used oils and fats, surfactants, moisturizing agents, whitening agents, pH adjusters, binders and thickeners, polyhydric alcohols, essential oils and fragrances, preservatives, antioxidants, UV absorbers, pigments, crushed plant products and herbal medicines, inorganic salts and inorganic acids, detergents, emulsifiers, etc.
[0023] Examples of the oils and fats include those commonly used in cosmetics, such as vegetable oils and fats such as soybean oil, almond oil, paraffin, cetanol, avocado oil, olive oil, jojoba oil, coconut oil, palm oil, rice bran oil, egg yolk oil, castor oil, squalane, lanolin, liquid paraffin, and white petrolatum; animal oils and fats such as beef tallow, lard, horse fat, turtle oil, mink oil, parcelin oil, and squalane; and synthetic oils and fats such as methylpolysiloxane, behenyl alcohol, glyceryl tricaprate, glyceryl trioctanoate, liquid paraffin, DHA, and EPA.
[0024] Examples of the surfactant include anionic surfactants such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and diethanolamide laurate; cationic surfactants such as stearyl trimethylammonium chloride, cetyl trimethylammonium chloride, and benzalkonium chloride; nonionic surfactants such as glyceryl monostearate, sorbitan monostearate, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene hydrogenated castor oil, sucrose esters, and fatty acid amides, polymeric surfactants, fluorine-based surfactants, silicone-based surfactants, polypeptide derivatives, and natural surfactants.
[0025] Examples of the moisturizing agents include synthetic moisturizing agents such as sodium pyrrolidone carboxylate and pantetheine-S sulfonate; and natural moisturizing agents such as hyaluronic acid, elastin, keratin, dermatan sulfate, collagen, placenta extract, royal jelly and their hydrolysates, microbial fermentation liquids such as chitin, chitosan, pectin, glucosamine, N-acetylglucosamine, and other plant- or animal-derived extracts, vegetable oils and their esters and derivatives.
[0026] Examples of the whitening agent include ascorbic acid and its salts and derivatives, arbutin and its derivatives, placenta extracts, and other plant- or animal-derived extracts.
[0027] Examples of the pH adjuster include organic acids such as citric acid, lactic acid, salicylic acid, tartaric acid, malic acid, benzoic acid, sodium citrate, fumaric acid, sodium monohydrogen phosphate, and potassium dihydrogen phosphate, as well as inorganic acids and salts thereof.
[0028] Examples of the binders and thickeners include those commonly used in cosmetics, such as sodium carboxymethylcellulose, methylcellulose, casein, pectin, starch, sodium alginate, polyvinyl alcohol, polyvinylpyrrolidone, locust bean gum, agar, carbopol, xanthan gum, and bentonite.
[0029] Examples of the polyhydric alcohols include glycerin, propylene glycol, sorbitol, polyethylene glycol, 1,3-butylene glycol, dipropylene glycol, polyoxyethylene glycerin (26E.O), and the like.
[0030] Examples of the essential oils and fragrances include natural and synthetic fragrances such as lavender oil, jasmine oil, rose oil, lemon oil, orange oil, peppermint oil, thyme oil, calamus oil, fennel oil, cedar oil, hiba oil, raspberry oil, cypress oil, rose oil, eucalyptus oil, camphor, peppermint oil, spearmint oil, geraniol, mandarin orange oil, spruce oil, citronellol, terpenes, coffee oil, tea oil, camellia oil, and raspberry ketone.
[0031] Examples of the preservative include paraoxybenzoic acid esters such as methylparaben, ethylparaben, propylparaben, and butylparaben, phenoxyethanol, ethanol, and dehydroacetic acid.
[0032] Examples of the antioxidant include EDTA4Na, EDTA2Na, butyloxytoluene, hydroxybutyltoluene, butylhydroxyanisole (BHA), dibutylhydroxytoluene (BHT), and derivatives thereof.
[0033] The ultraviolet absorber is not particularly limited as long as it has the property of selectively absorbing ultraviolet light, and examples thereof include oxybenzone, oxybenzone sulfonic acid, tetrahydroxybenzophenone, dihydroxymethoxybenzophenone sodium sulfonate, dihydroxymethoxybenzophenone, dihydroxybenzophenone, cinoxate, methyl diisopropylcinnamate, octyl methoxycinnamate, glyceryl para-aminobenzoate, and octyl para-aminobenzoate.
[0034] Examples of the pigment include red iron oxide, yellow iron oxide, black iron oxide, titanium oxide, nylon powder, zinc oxide, sericite, mica, talc, carbon, and medicinal charcoal.
[0035] Examples of the above-mentioned crushed plant materials and herbal medicines include crushed materials of lemon peel, seaweed, cypress, Japanese cypress, fucus, rice bran, calamus, ginger, licorice, tangerine peel, yuzu, angelica tree, carrot, mint, cinnamon bark, Ubai, mugwort, Houttuynia cordata, peach leaf, chamomile, aloe, jasmine, rose hips, lavender, guava, Scutellaria baicalensis, wolfberry, lychee, elderberry, angelica tree, Aralia aralia, burdock, black sesame, black rice, Fujisanchi ginseng, Korean ginseng, Panax notoginseng, Sekkotsu grass, and Cnidium rhizome, as well as dried materials and extracts thereof.
[0036] Examples of the inorganic salts and inorganic acids include sodium chloride, sodium bicarbonate, sodium carbonate, boric acid, borax, sodium sulfate, sodium sulfide, potassium sulfide, sodium nitrate, calcium nitrate, ammonium sulfate, sodium thiosulfate, calcium hydrogen phosphate, potassium chloride, ammonium chloride, sodium phosphate, sodium hyposulfite, calcium thiosulfate, sulfur, sodium sesquicarbonate, magnesium sulfate, magnesium chloride, silicic anhydride, metasilicic acid, boric acid, magnesium carbonate, magnesium hydroxide, magnesium dihydride, dried seawater, and the like.
[0037] Examples of the detergent include fatty acid soaps, sodium lauryl sulfate, anionic surfactants such as alkyl ether carboxylates, and aliphatic detergents.
[0038] The emulsifier may be any of the known cosmetic raw materials. Particularly preferred emulsifiers include sucrose fatty acid esters such as sucrose laurate, sucrose myristic acid ester, sucrose palmitate, sucrose stearate, sucrose oleate, and sucrose erucic acid ester; tetraglycerin monostearate, tetraglycerin monooleate, tetraglycerin tristearate, hexaglycerin monolaurate, hexaglycerin monomyristate, hexaglycerin monostearate, hexaglycerin tristearate, decaglycerin monolaurate, decaglycerin monomyristic acid ester, decaglycerin monostearate, decaglycerin distearate, decaglycerin monos ... polyglycerol fatty acid esters such as sorbitan tristearate, decaglycerol pentastearate, decaglycerol monoisostearate, decaglycerol diisostearate, decaglycerol pentaisostearate, decaglycerol monooleate, decaglycerol trioleate, and decaglycerol pentaoleate; sorbitan branched fatty acid esters such as sorbitan monoisostearate, sorbitan sesquiisostearate, and sorbitan triisostearate; soybean lecithin, egg yolk lecithin, hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, and further lecithins such as lysolecithin and / or hydrogenated lysolecithin obtained by enzymatically treating these lecithins to form monoacylated forms, and hydroxylated hydroxylecithin; and glycerol branched fatty acid esters such as glyceryl monoisostearate, glyceryl sesquiisostearate, and glyceryl diisostearate. One or more of these may be used in combination.
[0039] In addition to the above, the above-mentioned topical skin preparations can contain other ingredients as needed, such as milk-derived ingredients such as lactose, milk, condensed milk, etc.; inorganic pigments such as titanium, talc, etc.; bactericides such as isopropylmethylphenol, chlorhexidine hydrochloride, chlorhexidine gluconate, etc.; vitamins and coenzymes such as vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin P, CoQ10, CoQ9, CoQ8, thioctic acid, etc., fluidizing agents such as silicic anhydride, synthetic aluminum silicate, etc.; tar-based pigments for medicines, quasi-drugs, and cosmetics, etc.
[0040] In addition to the above-mentioned components, the above-mentioned external skin preparations can appropriately contain various cosmetic ingredients such as medicinal ingredients for the purposes of beauty, facial beauty, and skin treatment. The medicinal ingredients include avocado extract, amacha extract, althea extract, arnica extract, apricot extract, apricot kernel extract, ginkgo extract, fennel extract, turmeric extract, oolong tea extract, echinacea leaf extract, phellodendron bark extract, barley extract, Dutch mustard extract, orange extract, hydrolyzed wheat powder, hydrolyzed silk, chamomilla extract, carrot extract, artemisia capillaris extract, kalkade extract, kiwi extract, cinchona extract, cucumber extract, guanosine, kumazasa extract, walnut extract, grapefruit extract, clematis extract, yeast extract, comfrey extract, cowberry extract, psyllium serrata extract, umbilical cord extract, salvia extract, soapwort extract, bamboo extract, hawthorn extract, shiitake mushroom extract, rehmannia extract, lime root extract, linden extract, meadowsweet extract, calamus root extract, white birch extract, horsetail extract, honeysuckle Examples of such extracts include laurel extract, common weed extract, hawthorn extract, elderberry extract, yarrow extract, peppermint extract, mallow extract, swertia britannica extract, taiso extract, thyme extract, clove extract, imperata grass extract, tomato extract, natto extract, wild rose extract, hibiscus extract, bakumondou extract, parsley extract, parietaria extract, kikiokoshi extract, bisabolol, coltsfoot extract, butterbur honey, tou extract, bupleurum extract, butcher's broom extract, grape extract, propolis, loofah extract, peppermint extract, linden extract, hop extract, pine extract, horse chestnut extract, skunk cabbage extract, soapberry extract, peach leaf extract, cornflower extract, eucalyptus extract, apple extract, lettuce extract, astragalus extract, rose extract, rosemary extract, and Roman chamomile extract.
[0041] In addition, anti-inflammatory agents such as ε-aminocaproic acid, glycyrrhizic acid, dipotassium glycyrrhizinate, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, and hydrocortisone, blood circulation promoters such as vitamin C, vitamin D, calcium pantothenate, biotin, nicotinamide, vitamin E, and vitamin E derivatives, vitamins such as β-carotene and carotenoid derivatives, active ingredients such as allantoin, diisopropylamine dichloroacetate, and 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as flavonoids, tannins, lignans, and saponins, wound healing agents such as γ-oryzanol and proteolytic enzymes, cepharanthin, capsicum tincture, hinokitiol, and garlic iodide. Extracts, pyridoxine hydrochloride, nicotinic acid, nicotinic acid derivatives, acetyl pantothenyl ethyl ether, estradiol, ethynyl esterradiol, capronium chloride, diphenhydramine hydrochloride, camphor, nonylic acid vanillylamide, nonanoic acid vanillylamide, piroctone olamine, glyceryl pentadecanoate, 1-menthol, menthol pyrrolidone carboxylate, mononitroguaiacol, urea, resorcinol, γ-aminobutyric acid, benzethonium chloride, mexiletine hydrochloride, auxin, female hormones and female hormone-like substances, cantharides tincture, cyclosporine, analgesics, tranquilizers, antihypertensives, antibiotics, antihistamines, antibacterial substances, and the like can also be arbitrarily blended.
[0042] The subject of administration of the skin external preparation of this embodiment is preferably a warm-blooded vertebrate, more preferably a mammal.In this specification, the mammal can be, for example, human, monkey, mouse, rat, rabbit, dog, cat, cow, horse, pig and other non-human mammals.The skin external preparation of this embodiment is preferably applied to the human subject who wants to improve skin irritation.
[0043] (Manufacturing method) The sulfated polysaccharide constituting the active ingredient of the irritation alleviator according to this embodiment can be produced from natural plant materials such as algae. The natural plant materials are powdered and dissolved in water. A salt that becomes a monovalent ion, such as sodium chloride, is added to the solution, and the solution is heated. After heating, the monovalent ion salt of the sulfated polysaccharide can be extracted by separating the mixture according to molecular weight.
[0044] Here, the term "natural plant raw materials" refers to any plant that exists in nature, including algae. Examples of such natural plant raw materials include, but are not limited to, brown algae (e.g., seaweeds of the genus Laminaria, seaweeds of the genus Undaria, seaweeds of the genus Lessonia, seaweeds of the genus Macrocystis, seaweeds of the genus Ecklonia, seaweeds of the genus Eisenia, Ascophyllum, Durvillea, etc.), red algae (e.g., seaweeds of the genus Eucheuma, seaweeds of the genus Porphyra, seaweeds of the genus Gelidium, seaweeds of the genus Gracilaria, seaweeds of the genus Porphyra, etc.), green algae (e.g., seaweeds of the genus Myrtle, seaweeds of the genus Ulva, seaweeds of the genus Lavera, seaweeds of the genus Lycopersicon, seaweeds of the genus Acanthus, etc.), etc. Examples of other plants include, but are not limited to, citrus fruits, sugar beets, apples, etc. Of these, algae, particularly red algae, are preferred, and a representative example is that made from seaweed of the genus Funori.
[0045] In a preferred embodiment, the method for producing an irritation alleviator includes the steps of dissolving funori powder in water to prepare a funori aqueous solution, adding monovalent cations to the funori aqueous solution and heating it, and fractionating the heated aqueous solution by molecular weight to recover sulfated polysaccharide salts. Instead of this heating step, the method may include the steps of adding an acid (hydrochloric acid, sulfuric acid, or organic acid) to the funori aqueous solution to make it acidic, then desalting it, and adding monovalent cations to the desalted aqueous solution to neutralize it. Then, by separating it by molecular weight, sulfated polysaccharide salts salified with monovalent cations can be recovered.
[0046] The salt serving as the monovalent cation used in the heating step is not particularly limited, but may be, for example, sodium chloride, potassium chloride, sodium sulfate, potassium sulfate, etc. The amount of these salts added to the hot water is not particularly limited, but may be, for example, 0.0001 to 10 mol / L, further, for example, 0.001 to 5 mol / L, 0.01 to 2 mol / L, and preferably 0.1 to 1 mol / L.
[0047] The temperature of the hot water in the heating step is not particularly limited, but is, for example, 40°C or higher, and further, for example, 50°C or higher, 60°C or higher, 70°C or higher, 80°C or higher, 90°C or higher, 100°C or higher, or 120°C or higher. As a specific example, the heating step is performed at normal pressure (1013 hPa±50 hPa) and a temperature of 100°C or lower, for example, 55 to 65°C, using water as a solvent.
[0048] The time required for this heating may vary depending on the temperature selected, but may be from 1 hour to 2 months, for example, 1 hour to 1 month, 1 hour to 15 days, 1 hour to 10 days, 1 hour to 5 days, 1 hour to 3 days, 1 hour to 2 days, 1 hour to 1 day, 5 hours to 1 month, 5 hours to 15 days, 5 hours to 10 days, 5 hours to 5 days, 5 hours to 3 days, 5 hours to 2 days, 5 hours to 1 day, 10 hours to 1 month, 10 hours to 15 days, 10 hours to 10 days, 10 hours to 5 days, 10 hours to 3 days, or 10 hours to 2 days.
[0049] The heating step may include mixing the raw material funori in water containing monovalent cations as a solvent and leaving it for a certain period of time. This leaving may include appropriate stirring.
[0050] The heating step is repeated one or more times, for example, one to five times. For example, it can be carried out once or a plurality of times at 40 to 50°C, 50 to 60°C, 60 to 70°C, 70 to 80°C, or 50 to 70°C. Furthermore, when the extraction is repeated a plurality of times, the temperature for each time may be different or the same, and for example, it is also possible to adopt an embodiment in which the temperature is gradually increased each time. It is preferably 50 to 60°C or higher, and more preferably 55°C or higher.
[0051] In the above heating step, if necessary, techniques such as pressurized liquid extraction (PLE), microwave assisted extraction (MAE), subcritical extraction (SE), or a combination of these can be used in combination. Subcritical extraction is subcritical water extraction (SWE). Subcritical water extraction is also called superheated water extraction or pressurized hot water extraction (PHWE).
[0052] Subsequently, the method of recovering the sulfated polysaccharide salt can be, for example, molecular weight fractionation of the solution after the heating step or neutralization step by a molecular weight fractionation membrane fractionation method, gel filtration method, or the like. As a molecular weight fractionation membrane fractionation method, molecular weight fractionation can be industrially performed using an ultrafiltration membrane, and a molecular weight fraction within a predetermined range can be prepared by using, for example, an MF membrane (microfiltration membrane) or a UF membrane (ultrafiltration membrane) such as Microza (product name) manufactured by Asahi Kasei Corporation. As an example of the gel filtration method, Cellulofine GCL-300 manufactured by Seikagaku Corporation can be used. In addition, any molecular weight fraction can be prepared by combining these molecular weight fractionation methods and gel filtration methods.
[0053] The irritation alleviating agent produced by the method of the present embodiment can be further mixed with a pharmacologically or cosmetically acceptable carrier to produce an external preparation for skin. The external preparation for skin and the pharmacologically or cosmetically acceptable carrier are as described above.
[0054] The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. In the following examples, the unit % of the numerical values showing the amount of each component added means % by mass. EXAMPLES
[0055] (Production Example 1) Water was added to the powdered dried seaweed funori, and the ingredients were dissolved so as to loosen the tangled structure. The dissolved and insoluble parts were accurately separated to form single molecular units. Sodium chloride was added to the solution, and the solution was heated. After heating, the solution was separated according to molecular weight to extract the sodium salt of 6-position O-sulfated polysaccharide (hereinafter, this is referred to as "Funoran Na"). The structure of Funoran Na was analyzed by analysis of the reducing end sugar and sugar composition using a fluorescent labeling method using 2-aminopyridine, analysis of the sulfate content using a turbidimetric method using barium chloride, and NMR analysis, and it was confirmed that it has D-galactose as a sugar building block, and at least a part of this D-galactose sugar building block has a sulfate group at the 6-position. An aqueous solution containing 0.01 to 0.001% of the obtained sodium salt of 6-position O-sulfated polysaccharide was prepared, and this was used as a sample.
[0056] (Production Example 2) Funori (seaweed) was powdered and dissolved in water. Hydrochloric acid was added to the solution to make it acidic, and it was then desalted and neutralized with sodium hydroxide. After desalting again, it was separated by molecular weight, and the sodium salt of 6-position O-sulfated polysaccharide (Funoran Na) was extracted.
[0057] (Example 1) Test for alleviating irritation with Funoran Na <Subject> Ten Japanese women aged between 20 and 60 at the time of obtaining consent, who were aware that they had sensitive skin that was easily irritated, participated in this study. These subjects had an average score of 2 or higher when stimulated with 5% lactic acid, the positive control for skin irritation testing using the following test method.
[0058] <Test Method> The skin irritation test is a test using human skin. After washing the face with warm water, the subject waited for 20 minutes in a quiet room to acclimate. An appropriate amount (approximately 20 μl) of a 5% lactic acid solution (5 g of cosmetic lactic acid dissolved in distilled water to make 100 mL) was applied to the right cheek as a positive control, and the subject was asked to evaluate the irritation felt immediately after application (30 seconds later), 2 minutes after application, and 5 minutes after application according to the following criteria. After the evaluation, the test area was promptly washed with cold or warm water without rubbing.
[0059] [Table 1]
[0060] The evaluation score was the average score obtained by dividing the total scores immediately after application (30 seconds later), 2 minutes after application, and 5 minutes after application by the number of observations (3). In order to observe the weak stimulation, the subjects were instructed not to talk during the test and to concentrate on the test.
[0061] <Irritation alleviation test> A 5% lactic acid solution containing 1 ppm of Funoran Na was prepared as the test product using the sample prepared in Production Example 1. Approximately 20 μl of this test product was applied to the skin of the subjects, and the average scores were recorded immediately after application (after 30 seconds), 2 minutes after application, and 5 minutes after application, in the same manner as in the skin irritation test. After the evaluation was completed, the test area was promptly washed with cold or warm water without rubbing.
[0062] <Test Results> The results, judged according to the same criteria as in Table 1, are shown in Table 2 below and FIG. [Table 2]
[0063] As shown in Table 2 and Figure 1, it was found that the average score was significantly lower when a sample containing 1 ppm of Funoran Na was applied compared to when a 5% lactic acid solution used as the positive control was applied.
[0064] Example 2 Using a 5% lactic acid solution (about 20 μl) containing 0.1 ppm or 0.01 ppm of Funoran Na, an irritation alleviation test was carried out in the same manner as in Example 1. The results are shown in Table 3 below.
[0065] [Table 3]
[0066] As shown in Table 3, when Funoran Na was added at 0.1 ppm or 0.01 ppm, there was a tendency for the average score to decrease compared to the positive control. These skin irritation assessment results demonstrated that at 0.1 ppm or less, the irritation-reducing effect of Funoran Na decreased in a concentration-dependent manner, while at 1 ppm or more, the irritation-reducing effect was proven to be definite, demonstrating that adding 0.01 to 1 ppm of Funoran Na to substances or products that may irritate the skin is effective as an irritation-reducing material. [Industrial Applicability]
[0067] By simply adding an extremely small amount of the irritation-relieving agent of the present invention to any cosmetic product, such as a skin care product or makeup product, it may be possible to provide topical skin preparations, such as medicines and cosmetics, that can be freely used without any discomfort by people who have previously experienced skin discomfort from cosmetic products.
Claims
1. An irritation-relieving agent comprising a sulfated polysaccharide salt having a sulfate group in at least one sugar unit structure, said sulfate group forming a salt with a monovalent cation.
2. The irritation-relieving agent according to claim 1, wherein the sulfated polysaccharide salt has one or more hexose structural units selected from the group consisting of fucose, rhamnose, galactose, glucose, mannose and fructose, and at least one of the hexose unit structures has a sulfate group.
3. 2. The irritation-relieving agent according to claim 1, wherein the sulfated polysaccharide salt is the sodium salt of funoran, a polysaccharide derived from Funori.
4. 4. An external skin preparation comprising the irritation-relieving agent according to claim 1 in an amount of 0.000001% by mass to 0.01% by mass, calculated as the solid content of the sulfated polysaccharide salt.
5. A step of dissolving funori powder in water to prepare a funori aqueous solution; adding monovalent cations to the aqueous solution of funori and heating the solution; a step of recovering a sulfated polysaccharide salt by molecular weight fractionation of the aqueous solution after heating; A method for producing an irritation alleviator, comprising:
6. A step of dissolving funori powder in water to prepare a funori aqueous solution; A step of adding an acid to the funori aqueous solution to make it acidic and then desalting it; neutralizing the desalted aqueous solution by adding monovalent cations; a step of recovering a sulfated polysaccharide salt by molecular weight fractionation of the neutralized aqueous solution; A method for producing an irritation alleviator, comprising:
Citation Information
Patent Citations
External agent for skin
JP1995196443A
Mucopolysaccharide of glue and therapeutic agent containing the same as active ingredient
JP1995330804A
Dermal composition for external use
JP1996259443A
Skin cosmetic
JP1996283138A
Skin lightening cosmetic
JP2012121865A
